Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,222 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes

NCT01866228

Conditions: Adenocarcinoma, Behavior, Brain Diseases, +20 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

British Columbia Cancer Agency Vancouver, British Columbia, Canada

Cancer Care Manitoba Winnipeg, Manitoba, Canada

View Trial Details

Completed

Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy

NCT03438279

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Boston, Massachusetts, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00056134

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Erlangen Erlangen, Germany

View Trial Details

Completed

fPAM for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth

NCT02613325

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

NCT01079741

Conditions: Carcinogenesis, Melanoma, Neoplasms, +13 more
Locations: New York University Langone Medical Center New York, United States

View Trial Details

Completed

Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas

NCT00766753

Conditions: Glioma, Malignant Glioma, Neoplasms, +6 more
Locations: Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

NCT03199846

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Morristown, New Jersey, United States

View Trial Details

Completed

Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma

NCT00782756

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +16 more
Locations: Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

NCT01390571

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Bristol Haematology and Oncology Centre Bristol, England, United Kingdom

Addenbrooke's Hospital Cambridge, England, United Kingdom

Christie Hospital Manchester, England, United Kingdom

Royal Marsden Hospital Sutton, England, United Kingdom

View Trial Details

Completed

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma

NCT01632228

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: University of Alabama At Birmingham; Neuro-Oncology Birmingham, Alabama, United States

Cedars Sinai Medical Center; Neurosurgery Los Angeles, California, United States

UCLA Los Angeles, California, United States

USCF - Neurosurgery San Francisco, California, United States

View all 62 locations

View Trial Details